Elios Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$669K Sell
4,380
-116
-3% -$17.8K 0.3% 68
2025
Q1
$746K Buy
4,496
+66
+1% +$10.3K 0.37% 57
2024
Q4
$641K Buy
4,430
+8
+0.2% +$1.24K 0.3% 61
2024
Q3
$717K Buy
+4,422
New +$705K 0.33% 57

Other funds holding JNJ

Elios Financial Group's JNJ Position: Q2 2025 in Review

Elios Financial Group reduced its Johnson & Johnson (JNJ) stake by 2.6% in Q2 2025, selling an estimated $17.8K and leaving 4,380 shares worth $669K. The position accounts for 0.3% of the portfolio, ranked #68.

Elios Financial Group first reported a position in JNJ in Q3 2024 and has held it in 4 quarters since. The position peaked at $746K in Q1 2025. 4,090 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • Elios Financial Group held 4,380 shares of Johnson & Johnson worth $669K as of Q2 2025.
  • Elios Financial Group sold 116 Johnson & Johnson shares in Q2 2025, an estimated $17.8K.
  • Johnson & Johnson made up 0.3% of Elios Financial Group's portfolio in Q2 2025, its #68 holding.
  • Elios Financial Group first reported a position in Johnson & Johnson in Q3 2024 and has held it in 4 quarters since.
  • Elios Financial Group's Johnson & Johnson position peaked at $746K in Q1 2025.
  • 4,090 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on Elios Financial Group's 13F filing for Q2 2025, filed 13 Aug 2025.